C. diff, which is short for Clostridioides difficile, is a type of bacteria that may cause serious problems in the digestive system. It is one of the most common causes of diarrhea linked to ...

Crestone Pharmaceuticals recently shared topline results from a phase 2 trial of its investigational drug treatment for Clostridioides difficile infection. Investigators evaluated the safety and ...

There are about half a million C. diff infections every year in the United States. About 30,000 people die from them annually. But if you’ve had C. diff, you’re more likely to get it again. About 1 in ...

Paul Feuerstadt, MD, FACG, AGAF, discusses how testing for Clostridioides difficile is recommended for hospitalized patients or outpatients with new-onset, unexplained diarrhea who have risk factors ...

Rebyota introduces a diverse array of beneficial bacteria to restore gut microbiota balance, differing from conventional FMT's direct stool transfer. It is a standardized, commercially prepared ...

Clostridioides difficile is a notoriously nasty intestinal bug, with few effective treatments and no approved vaccines. But the same technology that enabled the first COVID-19 vaccines has shown early ...

The Children's Hospital of Eastern Ontario says there are now four confirmed cases of Clostridium difficile (C. difficile). CHEO reported three cases last week, saying one of the people infected ...

BOULDER, Colo.--(BUSINESS WIRE)--Crestone, Inc. (“Crestone”) today announced positive topline results from the Phase 2 clinical trial evaluating CRS3123 in patients with Clostridioides difficile ...

The portion of our nervous systems responsible for the 'fight or flight' response can shape the severity of potentially deadly C. difficile infections, according to new research. The portion of our ...

The rate of Clostridium difficile infection is increasing, according to a study presented by Mayo Clinic researchers during Digestive Disease Week 2012. Researchers found the incidence of C. difficile ...